Virtu Financial’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Virtu Financial’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61,500	Closed	-$617K	–	2294
2021 Q4	$617K	Buy	61,500 +46,887	+321%	+$480K	0.06%	312
2021 Q3	$149K	Sell	14,613 -25,718	-64%	-$259K	0.01%	1012
2021 Q2	$404K	Buy	+40,331	New	+$408K	0.04%	573

Other funds holding MTACU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's MTACU Position: Q1 2022 in Review

Virtu Financial sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2022, closing a stake of 61,500 shares — an estimated $617K sold.

Virtu Financial first reported a position in MTACU in Q2 2021 and held it in 3 quarters. The position peaked at $617K in Q4 2021. 5 funds tracked by Wall St. Rank hold MTACU as of Q1 2022.

Virtu Financial reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
Virtu Financial sold 61,500 MedTech Acquisition Corporation Unit shares in Q1 2022, an estimated $617K.
Virtu Financial first reported a position in MedTech Acquisition Corporation Unit in Q2 2021 and held it in 3 quarters.
Virtu Financial's MedTech Acquisition Corporation Unit position peaked at $617K in Q4 2021.
5 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.